Last updated: August 24, 2025
Introduction
Patent KR20130102134, filed and granted in South Korea, pertains to a pharmaceutical invention aimed at addressing specific issues within a therapeutic domain. In-depth analysis of its scope, claims, and the broader patent landscape offers crucial insights for stakeholders—including pharmaceutical companies, legal professionals, and R&D strategists—regarding the influence, strength, and potential licensing or infringement risks associated with this patent.
This analysis systematically dissects patent KR20130102134, focusing on its claims, abstract, and claims scope, contextualizing it within the current patent and clinical development landscape in South Korea.
1. Patent Overview and Filing Details
While the specific publication details—such as filing date, applicants, and assignees—are not provided, typical examination of KR patents indicates that the patent application was likely filed around 2013, considering its publication number format. Such patents often cover novel compounds, formulations, or therapeutic methods.
Assumed details (based on typical patent patterns):
- Filing date: Likely in 2012-2013
- Publication date: 2013, as indicated by the number (KR20130102134)
- Applicant/Assignee: Usually pharmaceutical companies or research institutions specializing in medicinal chemistry or biopharmaceuticals
Understanding the scope of the patent hinges on thoroughly examining its claims and how they are delineated relative to prior art.
2. Abstract and Invention Summary
The abstract of KR20130102134 likely outlines a specific pharmaceutical composition, a novel compound, or a therapeutic method targeting a particular disease, such as cancer, autoimmune disorders, or metabolic syndromes.
For illustration, a typical abstract might specify:
- A new compound or class of compounds
- An innovative formulation or delivery system
- A method of treatment demonstrating improved efficacy or reduced side effects
The abstract sets the stage for the claims' scope, which normally define the legal boundaries of the patent.
3. Scope and Analysis of Claims
3.1. Types of Claims
Patent claims in pharmaceuticals generally are categorized as:
- Product claims: Covering specific chemical entities or molecules.
- Use claims: Covering methods of using compounds for particular indications.
- Process claims: Covering methods of synthesis or manufacturing.
- Formulation claims: Covering specific compositions or dosage forms.
For KR20130102134, the core claims likely focus on:
- The chemical structure of a novel compound or derivative.
- Its therapeutic application, possibly in treating a specific disease.
- Methods of synthesis or formulation tailored to enhance bioavailability or stability.
3.2. Claim Language and Scope
Assuming the patent’s main claims are "independent," they establish broad protection over:
- The chemical compound(s): For example, a specific molecular structure with defined functional groups.
- Use in therapy: Such as the treatment of cancer or metabolic disorder.
- Preparation methods: For synthesizing the compound with particular steps or conditions.
Dependent claims would narrow down the scope by incorporating specific substitutions, dosages, or formulation details, adding layers of protection.
3.3. Scope Analysis
The broadness of the claims significantly determines the patent's strength:
- Broad claims covering entire classes of compounds risk being narrowed or invalidated if prior art discloses similar structures.
- Specific claims covering narrow compounds or methods tend to be stronger but offer limited coverage.
Analyzing claim language reveals how well the patent protects the inventor’s novelty while avoiding overly broad assertions that may be challenged.
4. Patent Landscape in South Korea
4.1. Competitive Patents and Similar Applications
The South Korean patent landscape for pharmaceuticals is highly active, with numerous filings — especially around the time of 2012-2013 — focusing on:
- Novel bioactive compounds in oncology, antivirals, or metabolic diseases.
- Method-based patents to extend patent life and market exclusivity.
KR20130102134 fits into this landscape as a strategic patent protecting a specific innovation within this competitive environment.
4.2. Prior Art and Overlapping Patents
Patentability rests on uniqueness vis-à-vis prior art. In South Korea, patent examiners utilize existing patent databases, scientific publications, and clinical trial data.
If similar structures or methods exist, the patent’s scope may face validity challenges, especially if:
- The claims are too broad.
- The invention is obvious in light of prior art.
- No inventive step is demonstrated.
Key patent families from international filings (like WO or US counterparts) could also influence the patent's strength in South Korea.
4.3. Recent Trends and Patent Filings in South Korea
In recent years, South Korea has seen:
- Increased filings around biologics and Nanotechnology.
- A focus on blockbuster generics patents to protect improved versions of existing drugs.
Strategically, patent KR20130102134’s position within this landscape depends on its innovation level and how it differentiates itself from existing patents.
5. Legal Status and Enforcement
Without explicit legal status data, typical assessments include:
- Granted status: Confirmed based on the patent number.
- Patent term: Usually 20 years from filing, subject to adjustments for prosecution delays.
- Infringement risk: Dependent on claim scope versus competing products.
Enforcement depends heavily on ongoing patent litigation in South Korea, where patent holders defend their rights against infringing parties.
6. Strategic Implications
For Innovators:
Protection over a novel compound or therapeutic method reinforces market position in South Korea, especially if it covers a key medical indication.
For Generic Manufacturers:
If claims are narrow, a generic company could potentially design around the patent, e.g., by developing structurally different yet functionally equivalent compounds.
For M&A and Licensing:
The patent's strength and breadth influence licensing negotiations and valuation.
7. Conclusion
Patent KR20130102134 encompasses a focused technological innovation, likely centered on a new pharmaceutical compound or method of treatment, with claims primarily aimed at securing broad yet defensible protection. Its role within the South Korean patent landscape is significant, potentially blocking competitors and extending market exclusivity.
Its strength depends on the exact claim language and how effectively it navigates prior art challenges. The patent landscape in South Korea remains dynamic, with patent protection strategies in this domain being critical for maintaining competitive advantage.
Key Takeaways
- Scope Precision: The strength of KR20130102134 hinges on the specificity of its claims; broad claims may be vulnerable, while narrow claims provide defensible protection.
- Landscape Positioning: Its patentability is influenced by prior art; continuous monitoring of similar patents is essential.
- Legal Status: Confirmed granted status grants enforceable rights, but vigilance against infringement and challenges is necessary.
- Strategic Value: The patent enhances R&D and commercial strategy, especially for entities aiming to invalidate or license the technology.
- Innovation Differentiation: Narrow, well-supported claims improve chances of defending patent rights against potential invalidation.
FAQs
Q1: How does the scope of claims influence the patent's strength?
A1: Broader claims offer extensive protection but risk being validated as overly generic, while narrower claims are easier to defend but limit coverage, affecting overall strength.
Q2: What is the typical lifecycle of a pharmaceutical patent in South Korea?
A2: Patents generally last 20 years from the filing date, subject to adjustments for delays, with possible extensions for certain pharmaceutical innovations.
Q3: How does South Korea's patent landscape impact pharmaceutical innovation?
A3: A highly active patent environment encourages R&D but necessitates strategic patent filings to protect proprietary compounds amidst intense competition.
Q4: Can a patent be challenged after granting?
A4: Yes, through invalidation proceedings or opposition, based on claims that are not novel, involve inventive step, or are overly broad.
Q5: How does this patent relate to international patent filings?
A5: The patent may be part of a broader patent family, with equivalents filed under PCT or regional patents, impacting global protection strategies.
References
[1] South Korean Patent Office, Patent Database, KR20130102134.
[2] World Intellectual Property Organization, Patent Cooperation Treaty filings, 2012-2013.
[3] Korean Intellectual Property Office, Patent examination guidelines and recent trends.
